Blog - Page 3773 of 5618

FridayMay 07, 2010 11:10 am

NewCardio, Inc. (NWCI.OB) to Offer Live Demo of CardioBip Handheld ECG Monitor

NewCardio, Inc. of Silicon Valley, which is hard at work commercializing a revolutionary new series of electrocardiography (ECG) products for diagnosing the health of the human heart, announced today the showcasing of its Cardio3KG™ (3-D ECG imaging software solution), QTinno™ (QT interval analytical suite), and the unveiling of its new patented, handheld wireless device, the CardioBip™, which can easily be used by anyone and generates the industry standard 12 lead ECG data. Both will be displayed this May 12-15 in booth #2147 at the Heart Rhythm Society’s (HRS) 31st Annual Scientific Sessions conference at the Denver Convention Center in Colorado.…

FridayMay 07, 2010 11:07 am

Crude Oil Prices Have a Rough Week

Crude oil prices were rather volatile on Friday morning, following an 11 percent sell-off so far this week. Oil prices have fallen from an 18-month high of $87.15, which was hit on Monday. Oil was driven lower by the continued turmoil in Europe and specifically the debt situation in Greece. The Euro itself hit a 14-month low this week at about $1.25 versus the US dollar. Concerns continue to grow that the debt crisis will spread from Greece to other weak European economies including Portugal, Spain, Italy and Ireland. If these countries are forced to make drastic budget cuts, it…

FridayMay 07, 2010 11:05 am

Helix BioMedix, Inc. (HXBM.OB) Reports First Quarter 2010 Financial Results

Helix BioMedix Inc. is a biopharmaceutical company with an extensive library of diverse bioactive peptides and patents covering six distinct classes and hundreds of thousands of peptide sequences. Applications for the company's peptides include anti-aging cosmeceutical skin care and acne treatment as well as other topical anti-infective pharmaceuticals and wound healing applications. The company today announced financial results for its first quarter 2010, which ended March 31, 2010. Revenue for the first quarter of 2010 was approximately $70,000 compared to revenue of about $87,000 in the prior year first quarter. Gross margin improved to 64.9% in the first quarter compared…

FridayMay 07, 2010 8:52 am

American Sierra Gold Corp. (AMNP.OB) Video Chart for Friday, May 7, 2010

The AMNP chart is at a point where it is time to make a decision. Many of the indicators have set-up nicely over the last couple months and now are at a “make-or-break” point. Please click the following link: http://www.qualitystocks.net/videocharts.php?chartvid_id=392 Let us hear your thoughts below:

FridayMay 07, 2010 8:40 am

Micro Identification Technologies, Inc. (MMTC.OB) Showcased as ‘Shining a Light on Food-Borne Illnesses’ by HealthNewsDigest.com

Micro Identification Technologies, Inc. recently announced its profile in HealthNewsDigest.com. The article featuring the company is an excellent source for readers and experts who want to learn more about the importance of innovative ways to protect food safety. Written by biochemist Michael D. Shaw, the article showcases MIT's proprietary technology and emphasis on preventing food-borne illnesses. Readers can view the article at: http://www.healthnewsdigest.com/news/contributing%20columnist0/Shining_A_Light_On_Food-Borne_Illnesses.shtml Mr. Shaw wrote, "Two distinct advantages of [MIT's] method are the very quick identification time (less than 10 minutes), and the low cost ($0.10 per test). 23 species can now be identified with this technique. An upcoming…

FridayMay 07, 2010 8:27 am

Stellar Pharmaceuticals, Inc. (SLXCF.OB) Signs Licensing Agreement with medac GmbH

Canadian pharmaceutical developer Stellar Pharmaceuticals Inc. reported that they signed a licensing agreement with medac GmbH for the distribution and sale of one of its lead products, Uracyst®. The product, a sterile sodium chondrotin solution used to treat interstitial cystitis/painful bladder syndrome, will be marketed in Germany and Austria; there, the product is trademarked as Uropol®. With the approved CE mark for the product already in place, the company expects that medac will launch Uropol® in the third quarter of 2010. The agreement has an initial five-year term with additional two-year renewal periods, and under the terms of the agreement,…

FridayMay 07, 2010 8:26 am

MedaSorb Technologies Corp. (CTSO.OB) Announces Company Name Change and New Ticker Symbol

MedaSorb Technologies Corporation announced yesterday that they have formally changed their company name to CytoSorbents Corporation. Along with this corporate name change, the new ticker symbol for the Company will be CTSO.OB, effective at the open of business on Friday, May 7, 2010. MedaSorb Technologies Corporation formerly traded under the symbol MSBT.OB. CytoSorbents Corporation, and their operating subsidiary CytoSorbents, Inc., is a therapeutic device company. They are in clinical trials to treat severe sepsis with a novel blood purification device called CytoSorb™. Severe sepsis often goes by the name "overwhelming infection." The triggering of severe sepsis is usually by bacterial…

FridayMay 07, 2010 8:24 am

ADVENTRX Pharmaceuticals, Inc. (ANX) Closes On Preferred Stock Offering

ADVENTRX Pharmaceuticals, Inc. reported the completion of an already disclosed sale of stock in a direct offering to several institutional investors. Rodman & Renshaw, LLC was the placement agent for the offering. ADVENTRX Pharmaceuticals, Inc. received gross proceeds of $19.2 million in the sale, and will use the proceeds to continue research on its main products, the acquisition of new products and general corporate purposes. ADVENTRX Pharmaceuticals, Inc. issued Series F convertible preferred stock to the investor group that is convertible into common shares of ADVENTRX Pharmaceuticals, Inc. at a conversion price of $3.7025 per share. The preferred stock also…

ThursdayMay 06, 2010 3:30 pm

Silver Pearl Enterprises Inc. (SVPE.OB) Secures Relationship with Hampton Growth to Boost IR Solutions and Market Penetration

Silver Pearl Enterprises Inc. (to be renamed Keyuan International Group Limited), a leading independent manufacturer and supplier of various petrochemical products in China, today announced it has retained Hampton Growth for its investor relations services and to support international market reach. Hampton is expected to correlate with and complement actions of HC International Inc., which will provide traditional investor relations activities and institutional investor management for the company. "We are excited to be working with Hampton Growth and look forward to them assisting us to maximize the value of our enterprise by providing exposure to their vast network of retail…

ThursdayMay 06, 2010 2:50 pm

LSB Financial Corp. (LSBI) Reports Higher Net Income in First Quarter of 2010

LSB Financial Corp. reported net income of $0.53 million, or $0.34 per diluted share, in the first quarter of 2010. The bank earned net income of $0.30 million, or $0.20 per diluted share, in the same quarter of 2010. Management of LSB Financial Corp attributed the strong improvement in earnings to cost control efforts that more than offset the fall in interest income that the bank received. Randolph F. Williams, the CEO of LSB Financial Corp, said, “The fundamentals of the bank are strong as seen in the 23.5% increase in net interest income and a 5.3% reduction in non-interest…

Site Search

Company Search